Microbiome on a chip: a promising technology for modeling of human organ microbiomes and their interactions

Marzieh Ramezani Farani1, Saber Saharkhiz2, Kimia Feiz3

  • 1Department of Biological Sciences and Bioengineering, NanoBio High-Tech Materials Research Center, Inha University, Incheon, Republic of Korea.

PubMed

Insights

Organ-on-a-chip (OoC) technology advances human health research by modeling organ functions. Microbiome-on-a-chip (MoC) systems offer a novel in vitro approach to study host-microbe interactions and develop targeted therapies.

Area of Science:

  • Microbiology
  • Biotechnology
  • Systems Biology

Background:

  • Organ microbiome research is crucial for understanding human health and disease.
  • Traditional animal models and in vitro systems have limitations in accurately reflecting human responses.
  • Organ-on-a-chip (OoC) technology provides a more human-relevant in vitro model for organ function simulation.

Purpose of the Study:

  • To introduce Microbiome-on-a-chip (MoC) as an advanced in vitro system for studying organ microbiomes.
  • To highlight the advantages of MoC over other in vitro methods for observing microbial dynamics and host interactions.
  • To review current MoC applications, fabrication methods, and future potential in microbiome engineering.

Main Methods:

  • Review of organ-on-a-chip (OoC) and microbiome-on-a-chip (MoC) technologies.
  • Discussion of MoC platforms for simulating oral, skin, gut, and vaginal microbiota.
  • Exploration of microfluidics and 3D printing as common MoC fabrication techniques.

Main Results:

  • MoC systems enable real-time monitoring of microbial growth, ecological dynamics, and host-microbe interactions.
  • MoC platforms can be engineered to test microbiome-therapies, study pharmacology, and investigate antibiotic resistance.
  • The technology facilitates modeling of multi-organ interactions mediated by the microbiome.

Conclusions:

  • Microbiome-on-a-chip (MoC) technology represents a significant advancement for in vitro microbiome research.
  • MoC platforms offer a powerful tool for developing microbiome-based diagnostics and therapeutics.
  • Future applications include microbiome engineering and personalized medicine approaches.

Related Concept Videos

iChip01:24

iChip

The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
77
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
98
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
41